• Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022
  • Revenue was $5,351,509, up by 52 per cent YoY
  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future
  • Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally
  • Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share

Nextleaf (OILS) has announced audited financial results for fiscal 2022, which ended September 30, 2022.

Select financial highlights

  • Revenue was $5,351,509, up by 52 per cent YoY
  • Cost of sales was $3,748,621, down by 12 per cent YoY
  • Gross profit came in at $661,238

Select operational highlights

  • The company ended 2022 as a top 5 seller of CBD oil and a top 10 seller in vapes across B.C.
  • It validated its technology to produce THC-free broad spectrum CBD distillate from industrial hemp feedstock. It launched its first THC-free CBD product subsequent to fiscal year end
  • It also became the first company in Canada to produce THC-O, which is not subject to excise tax

Subsequent to fiscal year end, Nextleaf entered the Newfoundland and Labrador market and completed its first international shipment of cannabis vape products.

CEO Paul Pedersen sat down with Coreena Robertson to add context to the results and discuss what to expect from the company in the future.

Nextleaf Solutions is a manufacturer and distributor of cannabis vapes and oils across Canada and internationally. Its flagship brand is the award-winning Glacial Gold.

Nextleaf (OILS) is down by 10 per cent trading at $0.045 per share as of 1:04 pm EST.


More From The Market Online
Organigram

Organigram reports record Q2 fiscal 2025 results

Organigram (TSX:OGI) announced its financial results for its Q2 of fiscal 2025, showing off notable growth...
Cannabis Report above an image of cannabis

StockTalk | Cannabis Report: New faces, new products

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.

Innocan secures Mexican patent for topical pain-relief technology

Pharmaceutical biotechnology company Innocan Pharma (CSE:INNO) announced a significant milestone in its global intellectual property strategy.
Cannabis Report image of farmed cannabis plants

StockTalk | Cannabis Report: Breathalyzers, record cash flow, & the funk

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks.